Loading...

TIAM1 variants improve clinical outcome in neuroblastoma

Identification of tumor driver mutations is crucial for improving clinical outcome using a personalized approach to the treatment of cancer. Neuroblastoma is a tumor of the peripheral sympathetic nervous system for which only a few driver alterations have been described including MYCN amplification...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Oncotarget
Main Authors: Sanmartín, Elena, Yáñez, Yania, Fornés-Ferrer, Victoria, Zugaza, José L., Cañete, Adela, Castel, Victoria, de Mora, Jaime Font
Format: Artigo
Sprog:Inglês
Udgivet: Impact Journals LLC 2017
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5542186/
https://ncbi.nlm.nih.gov/pubmed/28423360
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.16787
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!